Patent Assignment
Reel/Frame 047295/0577
Assignment of Assignor's Interest
Recorded: 2018-10-23
Pages: 27
Assignor
FAULK PHARMACEUTICALS, INC.
Executed: 2018-06-06
Assignee
REDOX THERAPEUTICS, LLC
309 FOREST LANE, LIBERTYVILLE, ILLINOIS, 60048
Covered Properties
(9)
Radioiodinated Apotransferrin for Use in Tumor Diagnosis, Imaging, Localization or Treatment
Patent:
4,895,714 →
Application:
07/064,939 →
Conjugates of Apotransferrin Proteins with Anti-Tumor Agents
Patent:
4,886,780 →
Application:
07/220,359 →
Conjugates of Proteins with Anti-Tumour Agents
Patent:
5,108,987 →
Application:
07/387,463 →
Treatment Method Utilizing Transferrin-Radioiodine Conjugate
Patent:
5,000,935 →
Application:
07/437,721 →
Targeted Delivery of Drugs for the Treatment of Parasitic Infections
Targeted Delivery of Bioaffecting Compounds for the Treatment of Cancer
Targeted Delivery of Bioaffecting Compounds for the Treatment of Cancer
Targeted Delivery of Drugs for the Treatment of Viral Infections
Anti-Cancer Compounds
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 13, 2000
From: FAULK, W. PAGE
To: FAULK PHARMACEUTICAL RESEARCH, LLC
Reel/Frame 010968/0216 →
Assignment of Assignor's Interest
Nov 17, 2003
From: FAULK, W. PAGE
To: FAULK PHARMACEUTICALS, INC.
Reel/Frame 015276/0216 →
Assignment of Assignor's Interest
Nov 17, 2003
From: FAULK, W. PAGE
To: FAULK PHARMACEUTICALS, INC.
Reel/Frame 015276/0245 →
Assignment of Assignor's Interest
Aug 2, 2010
From: HUANG, SUI; APPELLA, DANIEL; WITSCHI, MARK; NORTON, JOHN
To: NORTHWESTERN UNIVERSITY
Reel/Frame 024772/0121 →